Viewing Study NCT00002406


Ignite Creation Date: 2025-12-26 @ 5:18 PM
Ignite Modification Date: 2025-12-29 @ 2:42 AM
Study NCT ID: NCT00002406
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module